MFDS — authorised 2 March 2021
- Marketing authorisation holder: COMMCAVE THERAPEUTICS SA
- Status: likely_approved
🇰🇷 Azstarys in South Korea
MFDS authorised Azstarys on 2 March 2021
Marketing authorisation
Azstarys in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Azstarys approved in South Korea?
Yes. MFDS authorised it on 2 March 2021.
Who is the marketing authorisation holder for Azstarys in South Korea?
COMMCAVE THERAPEUTICS SA holds the South Korean marketing authorisation.